Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Operating Expenses (2020 - 2025)

Stemtech's Operating Expenses history spans 6 years, with the latest figure at $1.0 million for Q3 2025.

  • For Q3 2025, Operating Expenses fell 25.31% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $4.8 million, down 37.27%, while the annual FY2024 figure was $6.1 million, 24.93% down from the prior year.
  • Operating Expenses for Q3 2025 was $1.0 million at Stemtech, up from $853004.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $4.2 million in Q3 2022 and bottomed at $853004.0 in Q2 2025.
  • The 5-year median for Operating Expenses is $1.6 million (2023), against an average of $1.7 million.
  • The largest annual shift saw Operating Expenses skyrocketed 561.16% in 2021 before it crashed 62.66% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $2.7 million in 2021, then plummeted by 55.91% to $1.2 million in 2022, then soared by 116.92% to $2.6 million in 2023, then crashed by 60.61% to $1.0 million in 2024, then increased by 0.97% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for STEK's Operating Expenses are $1.0 million (Q3 2025), $853004.0 (Q2 2025), and $1.9 million (Q1 2025).